MedReleaf Corp. (LEAF) Given New C$20.00 Price Target at Canaccord Genuity

MedReleaf Corp. (TSE:LEAF) had its price target increased by equities research analysts at Canaccord Genuity from C$15.00 to C$20.00 in a note issued to investors on Tuesday. Canaccord Genuity’s price objective points to a potential upside of 9.59% from the stock’s previous close.

MedReleaf Corp. (TSE:LEAF) traded up C$1.10 during trading on Tuesday, reaching C$18.25. 896,924 shares of the company’s stock traded hands, compared to its average volume of 150,979. MedReleaf Corp. has a 1 year low of C$6.81 and a 1 year high of C$18.90.

WARNING: “MedReleaf Corp. (LEAF) Given New C$20.00 Price Target at Canaccord Genuity” was reported by Markets Daily and is the sole property of of Markets Daily. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at

In other MedReleaf Corp. news, insider Stephen Arbib sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of C$8.10, for a total value of C$81,000.00.

About MedReleaf Corp.

Receive News & Ratings for MedReleaf Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedReleaf Corp. and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply